Commentary on Bansback et al. (2018): Estimating the cost of stigma against injection

Addiction. 2018 Jul;113(7):1274-1275. doi: 10.1111/add.14219.
No abstract available

Keywords: Cost-effectiveness; MOUD; economics; health policy; injectable diacetylmorphine; injectable hydromorphone; methadone maintenance therapy; opioid dependence.

Publication types

  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Cost-Benefit Analysis
  • Heroin
  • Humans
  • Hydromorphone*
  • Methadone
  • Opioid-Related Disorders*

Substances

  • Heroin
  • Hydromorphone
  • Methadone